The recent disruptions in global chains have highlighted the necessity of securing essential medications like Ivermectin. Relying on overseas producers exposes countries to significant vulnerabilities, including shipping delays, expense fluctuations, and even trade concerns. Transitioning towards domestic sourcing of Ivermectin offers a multitude o